Skip to main content

Prescription medicine

Pivmecillinam Brand names: Pivya

Pivmecillinam (Pivya) is a prescription medicine with an FDA approval on record since 2024. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the pivmecillinam FDA label on DailyMed (effective October 10, 2025, Alembic Pharmaceuticals Inc.); the NDA 216483 record on Drugs@FDA; every pivmecillinam label on DailyMed.

Highlights of the record

FDA label of October 10, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

INDICATIONS AND USAGE PIVYA is a penicillin class antibacterial indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.

Forms and strengths

  • 185 mg

Coated tablet.

On the market

Earliest approval on file
April 24, 2024 Pivya, Alembic Therap; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
188 through July 30, 2026

What is pivmecillinam used for?

From the label: indications and usage

INDICATIONS AND USAGE PIVYA is a penicillin class antibacterial indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus. ( 1.1 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of PIVYA and other antibacterial drugs, PIVYA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. […]

Conditions named in the indications of pivmecillinam's FDA labels, with every medicine labeled for each:

From other pivmecillinam labels

Urinary tract infections: Uncomplicated Urinary Tract Infections PIVYA is indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli (E. …

Source: FDA drug label (PIVYA), Alembic Pharmaceuticals Inc., effective October 10, 2025 (SPL set 440a5f17-ab11-0fc8-e063-6394a90a58e9), via openFDA; the full label on DailyMed

Is there a generic for pivmecillinam (Pivya)?

No generic pivmecillinam is approved (Drugs@FDA, October 8, 2026).

  • 2024 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the pivmecillinam label say about other medicines?

The pivmecillinam label names 3 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Divalproexdrug interactionsDRUG INTERACTIONS 7.1 Other Pivalate-Generating Drugs Avoid concurrent treatment with valproic acid, valproate, or other pivalate-generating drugs.
Methotrexatedrug interactionsClearance of methotrexate from the body can be reduced by concurrent use of drugs in the penicillin class, including PIVYA. Where possible, consider alternative therapy.
Valproic aciddrug interactionsDRUG INTERACTIONS 7.1 Other Pivalate-Generating Drugs Avoid concurrent treatment with valproic acid, valproate, or other pivalate-generating drugs.

Check pivmecillinam against other medicines

Source: FDA drug label (PIVYA), Alembic Pharmaceuticals Inc., effective October 10, 2025 (SPL set 440a5f17-ab11-0fc8-e063-6394a90a58e9), via openFDA; the full label on DailyMed

What do FAERS reports show for pivmecillinam?

The FDA Adverse Event Reporting System holds 188 reports that list pivmecillinam among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 19 are coded as a death and 84 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Malaise20
  • Confusional State19
  • Urinary Incontinence13
  • Decreased Appetite12
  • Drug Interaction (a use or a product term, not a reaction)12
  • Diarrhoea (named in the label)11
  • Headache (named in the label)11
  • Rash (named in the label)11

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What else is labeled for the same conditions as pivmecillinam?

9 other medicines are given the same way (oral) and in the same FDA class as pivmecillinam or labeled mainly for the same use (urinary tract infections), the same class first. Urinary tract infections lists all 39 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.

MedicineShared indicationGeneric labelers (oral)Pharmacy costShortage
DoxycyclineUrinary tract infections71 labelers$0.118 per tablet 100 mg tabletA presentation being discontinued
Amoxicillin and clavulanateUrinary tract infections31 labelers$0.0693 per mL 600-42.9 mg/5 mL susNo current entry
NitrofurantoinUrinary tract infections47 labelers$0.165 per capsule 50 mg capsuleA presentation being discontinued
MinocyclineUrinary tract infections21 labelers$0.343 per capsule 100 mg capsuleNo current entry
MethenamineUrinary tract infections10 labelers$0.313 per tablet 1 g tabletNo current entry
FosfomycinUrinary tract infections10 labelers$26.22 per unit 3 g sachetNo current entry
SulfadiazineUrinary tract infections2 labelers$15.06 per tablet 500 mg tabletNo current entry
GepotidacinUrinary tract infectionsnone listed$91.40 per tablet 750 mg tabletNo current entry

Every medicine labeled for the same conditions as pivmecillinam

Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)

What next?

Alternatives to pivmecillinam
9 medicines for the same use
Pivmecillinam side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other